Case Report
Copyright ©The Author(s) 2022.
World J Hepatol. Sep 27, 2022; 14(9): 1830-1839
Published online Sep 27, 2022. doi: 10.4254/wjh.v14.i9.1830
Table 2 Management outcomes of published case series of primary hepatic leiomyosarcoma
Ref.
Patient age in yr
Sex
Treatment
Follow up
Almogy et al[22], 200458FSurgery + chemotherapyDeath at 4 mo
63FSurgery + chemotherapyDeath at 12 mo
Watanabe et al[34], 200863 FDiagnosis at autopsy
49FDiagnosis at autopsy
Matthaei et al[14], 200919FLiver transplantDeath at 73 mo
64FSurgeryNo evidence of disease 181 mo
53FSurgeryDeath at 21 mo
55MSurgeryNo evidence of disease at 133 mo
51MLiver transplantNo evidence of disease at 144 mo
59MSurgeryDeath at 45 mo
63FSurgeryNo evidence of disease at 133 mo
Shamseddine et al[23], 201025FRight lobectomyDeath at 22 mo
39MExtended right lobectomyDeath at 19 d
30MRight lobectomy + chemotherapyNo evidence of disease at 12 mo
Esposito et al[35] ,202078MLeft hepatectomyNo evidence of disease at 18 mo
53MRight extended hepatectomyLung metastasis at seven mo death at 14 mo